Delivery of ion pumps from exogenous membrane-rich sources into mammalian red blood cells

Mechanisms of sodium pump regulation

The Na(+)-K(+)-ATPase, or sodium pump, is the membrane-bound enzyme that maintains the Na(+) and K(+) gradients across the plasma membrane of animal cells. Because of its importance in many basic and specialized cellular functions, this enzyme must be able to adapt to changing cellular and physiological stimuli. This review presents an overview of the many mechanisms in place to regulate sodium pump activity in a tissue-specific manner. These mechanisms include regulation by substrates, membrane-associated components such as cytoskeletal elements and the gamma-subunit, and circulating endogenous inhibitors as well as a variety of hormones, including corticosteroids, peptide hormones, and catecholamines. In addition, the review considers the effects of a range of specific intracellular signaling pathways involved in the regulation of pump activity and subcellular distribution, with particular consideration given to the effects of protein kinases and phosphatases.

K(+)/Na(+) antagonism at cytoplasmic sites of Na(+)-K(+)-ATPase: a tissue-specific mechanism of sodium pump regulation

Tissue-distinct interactions of the Na(+)-K(+)-ATPase with Na(+) and K(+), independent of isoform-specific properties, were reported previously (A. G. Therien, N. B. Nestor, W. J. Ball, and R. Blostein. J. Biol. Chem. 271: 7104-7112, 1996). In this paper, we describe a detailed analysis of tissue-specific kinetics particularly relevant to regulation of pump activity by intracellular K(+), namely K(+) inhibition at cytoplasmic Na(+) sites. Our results show that the order of susceptibilities of alpha(1) pumps of various rat tissues to K(+)/Na(+) antagonism, represented by the ratio of the apparent affinity for Na(+) binding at cytoplasmic activation sites in the absence of K(+) to the affinity constant for K(+) as a competitive inhibitor of Na(+) binding at cytoplasmic sites, is red blood cell < axolemma approximately rat alpha(1)-transfected HeLa cells < small intestine < kidney < heart. In addition, we have carried out an extensive analysis of the kinetics of K(+) binding and occlusion to the cytoplasmic cation binding site and find that, for most tissues, there is a relationship between the rate of K(+) binding/occlusion and the apparent affinity for K(+) as a competitive inhibitor of Na(+) activation, the order for both parameters being heart >/= kidney > small intestine approximately rat alpha(1)-transfected HeLa cells. The notion that modulations in cytoplasmic K(+)/Na(+) antagonism are a potential mode of pump regulation is underscored by evidence of its reversibility. Thus the relatively high K(+)/Na(+) antagonism characteristic of kidney pumps was reduced when rat kidney microsomal membranes were fused into the dog red blood cell.